Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Pfizer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Thomas Jefferson University
Pfizer
Thomas Jefferson University
Mayo Clinic
Rutgers, The State University of New Jersey
Ethicon, Inc.
Wake Forest University Health Sciences
Pheon Therapeutics
National Cancer Institute (NCI)
Xemed LLC